Close to 20 years of pharma industry, covered a broad range of senior and executive leadership roles across R&D and Commercial, including Managing Director of Lundbeck Japan, and most recently as SVP Global Head of Experimental Medicine & Clinical Development at Lundbeck. MD with clinical training in Neurology, DMSc in Neuroscience; executive MBA from IMD. On the Board the of Directors for AptaTargets (independent), Cureteq and Oncoteq (Chair)